CureVac shares tank 50% after preliminary data shows Covid vaccine is only 47% effective

The late-stage clinical trial found high prevalence of virus variants.

from Health and Science https://ift.tt/3gwPyyx
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH